These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing, reported early 2004-000948-25 Determinación de niveles plasmáticos e intracelulares de los inhibidores de la transcriptasa inversa análogos a nucleósidos (NRTI) y del análogo a nucleótido tenofovir disoproxil fumarato (TDF) en pac... not-yet-due
Ongoing, reported early 2004-004802-26 ESTUDIO DE LA INFLUENCIA DE LAS ESTATINAS EN LA REPLICACIÓN PLASMÁTICA DEL VIH EN PACIENTES CON INFECCION POR EL VIH-1 QUE INTERRUMPEN EL TRATAMIENTO ANTIRRETROVIRAL not-yet-due
Ongoing 2005-002203-17 Estudio piloto unicéntrico, abierto, aleatorizado para evaluar la evolución inmuno-virológica y clínica de una combinación con análogos a nucleósidos/nucléotidos (TrizivirÒ +Tenofovir) en pacientes mu... not-yet-due
Ongoing 2005-002493-30 ENSAYO CLÍNICO PILOTO, ABIERTO, PARALELO Y ALEATORIZADO PARA EVALUAR LA UTILIDAD DE LA MONITORIZACIÓN TERAPEUTICA DE LOS NIVELES PLASMÁTICOS DE EFAVIRENZ EN PACIENTES INFECTADOS POR EL VIH QUE INICIA... not-yet-due
Ongoing 2005-005356-41 ESTUDIO DE LA INFLUENCIA DE ATORVASTATINA EN LA REPLICACIÓN VIRAL PLASMÁTICA CUANDO SE ADMINISTRAN PREVIAMENTE A LA INTERRUPCION DEL TRATAMIENTO ANTIRRETROVIRAL EN PACIENTES CON INFECCION POR EL VIH-... not-yet-due
Ongoing, reported early 2006-001136-47 ESTUDIO PILOTO, ABIERTO, COMPARATIVO Y RANDOMIZADO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE SAQUINAVIR/RITONAVIR EN MONOTERAPIA vs TERAPIA HAART ESTÁNDAR COMO TERAPIA DE MANTENIMIENTO not-yet-due
Ongoing 2006-005554-74 Estudio piloto para evaluar la eficacia y seguridad en las 12 primeras semanas de altas dosis de Ribavirina (1600 mg/día) con apoyo de Epoetina β (450 UI/kg/semana) en la terapia de inducción en pacie... not-yet-due
Reported results 2007-003801-28 IMPACTO DE LA INTENSIFICACIÓN CON RALTEGRAVIR EN LA LATENCIA VIRAL DE VIH-1 EN PACIENTES CON SUPRESIÓN VIRAL COMPLETA (IMPACT OF RALTEGRAVIR INTENSIFICATION ON HIV-1 VIRAL LATENCY IN PATIENTS WITH PRE... 2009-09-30 due-trials
Ongoing 2007-004519-67 ENSAYO CLÍNICO PROSPECTIVO, ABIERTO Y ALEATORIZADO, SOBRE LA SEGURIDAD HEPÁTICA DEL TRATAMIENTO ANTIRRETROVIRAL QUE INCLUYE KALETRA VS NEVIRAPINA EN PACIENTES COINFECTADOS VIH/VHC. ESTUDIO KANELA. not-yet-due
Ongoing, reported early 2007-004825-35 ENSAYO CLÍNICO PILOTO PARA EVALUAR LA SEGURIDAD DE LA REDUCCION DE DOSIS DE RITONAVIR EN PACIENTES INFECTADOS POR EL VIH EN TRATAMIENTO CON TIPRANAVIR/RITONAVIR 500/200 MG CADA 12 HORAS. not-yet-due
Reported results 2007-005951-40 DINAMICA VIRAL DEL VIH-1 EN SUJETOS QUE INICIAN TERAPIA CON RALTEGRAVIR (HIV-1 VIRAL DYNAMICS IN SUBJECTS INITIATING RALTEGRAVIR THERAPY) 2009-10-05 due-trials
Ongoing, reported early 2007-005979-34 ESTUDIO PILOTO, ABIERTO, COMPARATIVO Y ALEATORIZADO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE DARUNAVIR/RITONAVIR 900/100 MG UNA VEZ AL DIA COMO ESTRATEGIA DE SIMPLIFICACION DEL TRATAMIENTO ANTIRRETROVI... not-yet-due
Ongoing 2008-002695-94 CLINICAL TRIAL ASSESSING ONCE DAILY RALTEGRAVIR ADMINISTRATION (800 mg QD) IN HIV-1-INFECTED PATIENTS RECEIVING UNBOOSTED ATAZANAVIR (400 mg QD)-BASED ANTIRETROVIRAL THERAPY (ENSAYO CLÍNICO PARA EVALU... not-yet-due
Ongoing, reported early 2008-005051-18 ESTUDIO DE LA EFICACIA Y SEGURIDAD DEL ÁCIDO ZOLEDRÓNICO PARA EL TRATAMIENTO DE LA OSTEOPOROSIS EN UNA COHORTE DE PACIENTES CON INFECCIÓN POR EL VIH-1. not-yet-due
Ongoing, reported early 2008-005473-35 PILOT STUDY TO ASSESS THE ROLE OF IMMUNE ACTIVATION AND APOPTOSIS AS A MARKER FOR TREATMENT INTENSIFICATION WITH RALTEGRAVIR IN HIV-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY WITH LONG-TERM VIRAL SUP... not-yet-due
Completed, but no date, and reported results 2008-006065-87 EFFICACY OF TREATMENT INTENSIFICATION WITH MARAVIROC ON HIV-1 VIRAL LATENCY IN RECENTLY INFECTED HIV-1 NAÏVE PATIENTS STARTING RALTEGRAVIR PLUS TENOFOVIR/EMTRICITABINE. (EFICACIA DE LA INTENSIFICACIÓN... bad-data
Completed, but no date 2009-011868-11 ENSAYO CLÍNICO PILOTO PARA EVALUAR LA SEGURIDAD Y EFICACIA DE CAMBIAR EL ITINAN O EL IP A MARAVIROC EN PACIENTES INFECTADOS POR EL VIH-1 CON CARGA VIRAL INDETECTABLE Y DISLIPEMIA ASOCIADA A LOS ANTIRE... bad-data
Ongoing, reported early 2009-013265-26 INTERACCIONES FARMACOLÓGICAS ENTRE ECHINACEA PURPUREA Y DARUNAVIR/RITONAVIR not-yet-due
Ongoing, reported early 2009-013287-39 RANDOMISED AND PROSPECTIVE CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LOPINAVIR/RITONAVIR MONOTHERAPY VS DARUNAVIR/RITONAVIR MONOTHERAPIES AS SIMPLIFICATION SWITCHING STRATEGIES OF PI/NNRTI... not-yet-due
Reported results 2009-014313-27 ESTUDIO PILOTO PARA COMPARAR LOS PARÁMETROS FARMACOCINÉTICOS EN PLASMA E INTRACELULARES DE RALTEGRAVIR ADMINISTRADO UNA VEZ AL DÍA EN PACIENTES ADULTOS INFECTADOS POR EL VIH. 2009-12-15 due-trials
Ongoing, reported early 2009-016455-21 PILOT STUDY TO ASSESS THE EFFICACY AND SAFETY OF SWITCHING PROTEASE INHIBITOR TO ETRAVIRINE IN HIV-1-INFECTED SUBJECTS WITH VIREMIA SUPPRESSION (ESTUDIO PILOTO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE ... not-yet-due
Ongoing, reported early 2010-019446-38 Estudio Exploratorio Transversal para Comparar la Eficacia Virológica en el LCR y el Estado Neurocognitivo en Pacientes Infectados por el VIH-1 en Tratamiento Prolongado (> 3 años) con Lopinavir/riton... not-yet-due
Ongoing, reported early 2010-019879-29 MULTICENTRE STUDY TO ASSESS CHANGES IN BONE MINERAL DENSITY OF THE SWITCH FROM TENOFOVIR TO ABACAVIR IN HIV-1-INFECTED SUBJECTS WITH LOSS OF BONE MINERAL DENSITY (ESTUDIO MULTICÉNTRICO PARA EVALUAR LO... not-yet-due
Ongoing, reported early 2010-021159-25 INTERACCIONES FARMACOLÓGICAS ENTRE LA SILIMARINA Y DARUNAVIR/RITONAVIR not-yet-due
Completed, but no date, and reported results 2010-024510-57 Estudio Randomizado, Prospectivo, Controlado, para Comparar la Eficacia y Seguridad de Dos Estrategias Farmacológicas Diferentes sobre la Alteración Neurocognitiva en la Infección por VIH. Estudio TRI... bad-data
Completed, but no date, and reported results 2011-000799-32 Use of genotypic HIV-1 tropism testing in proviral DNA to guide CCR5 antagonist treatment in subjects with undetectable HIV-1 viremia bad-data
Completed, but no date, and reported results 2011-002853-77 PROSPECTIVE, RANDOMISED, CROSSOVER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO ASSESS THE LIPID-LOWERING EFFECT OF ADDING TENOFOVIR/EMTRICITABINE CO-FORMULATION VS PLACEBO TO HIV-1-INFECTED SUBJECTS WI... bad-data
Completed, but no date, and reported results 2011-006272-39 CLINICAL TRIAL TO EVALUATE THE EFFICACY, SAFETY AND ECONOMIC IMPACT OF REDUCING DOSES OF DARUNAVIR IN PATIENTS INFECTED WITH HIV TREATED WITH DARUNAVIR / RITONAVIR ONCE A DAY bad-data
Ongoing, reported early 2012-000198-21 A multicenter randomised opened study to assess the efficacy and safety of the withdrawal of nucleos/tide analogues in HIV-1-infected subjects with complete or intermediate resistance to these analogu... not-yet-due
Completed, but no date, and reported results 2013-000547-85 MULTICENTRE STUDY TO ASSESS CHANGES IN BONE MINERAL DENSITY OF THE SWITCH FROM PROTEASE INHIBITORS TO DOLUTEGRAVIR IN HIV-1-INFECTED SUBJECTS WITH LOW BONE MINERAL DENSITY bad-data
Ongoing 2015-000274-35 An open-label, randomized, controlled clinical trial to assess the safety, tolerability and efficacy of two dolutegravir-based simplification strategies in HIV-infected patients with prolonged virolog... not-yet-due
Completed, but no date, and reported results 2015-000856-16 Removal of dolutegravir by hemodialysis in HIV-infected patients with end-stage renal disease. bad-data
Completed, but no date 2015-002682-30 Raltegravir-based regimen versus raltegravir-based regimen plus atorvastatin for reducing ?inflamaging? (aging-related complication) in HIV-infected patients older than 60 years. bad-data
Ongoing 2016-001371-69 Tenofovir DP concentrations in seminal cells and semen quality in HIV-1 infected patients receiving a TAF containing regimen not-yet-due
Ongoing 2016-002722-36 Randomized, double-blind, placebo-controlled clinical trial to evaluate the effect of Raltegravir intensification (1.200 mg QD) on the gut microbiota of chronically HIV-1 infected subject over time: T... not-yet-due
Ongoing 2017-004750-42 EFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS CARRYING ARCHIVED MULTIDRUG RESISTANCE MU... not-yet-due
Completed, report not yet due 2018-000302-39 Bictegravir concentrations and antiviral activity in cerebrospinal fluid in HIV-1 Infected individuals 2018-09-25 not-yet-due
Ongoing 2018-002310-12 Bictegravir concentrations and antiviral activity in genital fluids and rectal compartment in HIV-1 infected individuals (“BIGER Study”). not-yet-due